Akebia Therapeutics Inc. buy HC Wainwright
Start price
27.09.23
/
50%
€1.11
Target price
27.09.24
€3.55
Performance (%)
-8.90%
Price
23.05.24
€1.01
Summary
This prediction is currently active. With a performance of -8.90%, the BUY prediction by HC_Wainwright is trending in the wrong direction. This prediction currently runs until 27.09.24. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Akebia Therapeutics Inc. | -5.463% | -5.463% |
iShares Core DAX® | -1.347% | 3.576% |
iShares Nasdaq 100 | 1.169% | 7.020% |
iShares Nikkei 225® | -0.327% | -0.673% |
iShares S&P 500 | 0.510% | 4.445% |
Comments by HC_Wainwright for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.75 price target on the stock.
Ratings data for AKBA provided by MarketBeat
Stopped prediction by HC_Wainwright for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.82
28.03.24
28.03.24
€5.55
28.03.25
28.03.25
-44.46%
23.05.24
23.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
17.11.23
17.11.23
€4.60
17.11.24
17.11.24
13.41%
23.05.24
23.05.24
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.27
28.08.23
28.08.23
€3.47
28.08.24
28.08.24
-20.24%
23.05.24
23.05.24